Vaccine Gets Go Ahead

Vaccine approach on existing MS patients passes safety trial. Verdict implies further study of the treatment is warranted.

Posted in news |

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.